Columbia Care LLC. has announced this morning that the company has gain approval from Malta Enterprises, the regulatory economic development agency in the country, to receive licenses within the country to import, export, cultivate, process, and distribute medicinal cannabis.
The company’s branded product lines such as ClaraCeed™, TheraCeed™ and EleCeed™ are consisted of proprietary pharmaceutical-quality medical cannabis derived products. . Colombia Care is expected to operate out of a GMP-certified and ISO-certified research and manufacturing facilityin Malta as well.
Columbia Care is a private company located in the United states. Currently, the company is a large-scale producer and manufacturer of medicinal cannabis products and owns a network of over 750,000 patients. Their company is now planning to take their proven concept to countries around the world, with Europe being its first target.
Nicholas Vita, Chief Executive Officer of Columbia Care gave this statement in the press release, “….we have become the global leader from our base in the U.S., raising the bar for expectations, performance and industry standards. With a desire to realize our mission regardless of geography, we look forward to disrupting the status quo outside the U.S. and bringing our expertise to the rest of the world.”